Indivior Pharmaceuticals, Inc. (INDV)
37.46
-0.13
(-0.35%)
USD |
NASDAQ |
May 21, 16:00
37.44
-0.02
(-0.04%)
After-Hours: 19:59
Indivior Pharmaceuticals Research and Development Expense (TTM) : 67.00M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.70M |
| Liquidia Corp. | 44.01M |
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| Viatris, Inc. | 965.80M |
| Theravance Biopharma, Inc. | 30.20M |